WC
TMO icon

Westhampton Capital’s Thermo Fisher Scientific TMO Stock Holding History

Westhampton Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
2,551
+63
+3% +$30.2K 0.53% 54
2026
Q1 		$1.22M Hold
2,488
– – 0.57% 53
2025
Q4 		$1.44M Buy
2,488
+30
+1% +$17K 0.68% 48
2025
Q3 		$1.19M Buy
2,458
+45
+2% +$20.9K 0.58% 51
2025
Q2 		$978K Buy
2,413
+168
+7% +$70.2K 0.51% 62
2025
Q1 		$1.12M Sell
2,245
-47
-2% -$25.5K 0.61% 56
2024
Q4 		$1.19M Buy
2,292
+75
+3% +$41.2K 0.61% 55
2024
Q3 		$1.37M Buy
2,217
+30
+1% +$17.8K 0.7% 51
2024
Q2 		$1.21M Hold
2,187
– – 0.66% 49
2024
Q1 		$1.27M Sell
2,187
-30
-1% -$16.8K 0.69% 50
2023
Q4 		$1.18M Buy
2,217
+60
+3% +$29K 0.7% 50
2023
Q3 		$1.09M Buy
2,157
+170
+9% +$90.6K 0.7% 50
2023
Q2 		$1.04M Hold
1,987
– – 0.67% 51
2023
Q1 		$1.15M Hold
1,987
– – 0.74% 48
2022
Q4 		$1.09M Hold
1,987
– – 0.74% 51
2022
Q3 		$1.01M Hold
1,987
– – 0.76% 49
2022
Q2 		$1.08M Buy
1,987
+62
+3% +$34.1K 0.76% 47
2022
Q1 		$1.14M Hold
1,925
– – 0.73% 46
2021
Q4 		$1.28M Hold
1,925
– – 0.79% 44
2021
Q3 		$1.1M Hold
1,925
– – 0.75% 46
2021
Q2 		$971K Buy
1,925
+200
+12% +$94.4K 0.63% 52
2021
Q1 		$787K Sell
1,725
-25
-1% -$11.9K 0.54% 59
2020
Q4 		$815K Hold
1,750
– – 0.61% 52
2020
Q3 		$773K Hold
1,750
– – 0.63% 49
2020
Q2 		$634K Sell
1,750
-100
-5% -$33.5K 0.55% 53
2020
Q1 		$525K Buy
1,850
+100
+6% +$31.5K 0.55% 55
2019
Q4 		$569K Hold
1,750
– – 0.46% 63
2019
Q3 		$510K Hold
1,750
– – 0.43% 64
2019
Q2 		$514K Buy
+1,750
New +$482K 0.43% 65

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Westhampton Capital's TMO Position: Q2 2026 in Review

Westhampton Capital increased its Thermo Fisher Scientific (TMO) stake by 2.5% in Q2 2026, buying an estimated $30.2K and bringing the position to 2,551 shares worth $1.28M. The position accounts for 0.53% of the portfolio, ranked #54.

Westhampton Capital first reported a position in TMO in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.44M in Q4 2025. 875 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Westhampton Capital held 2,551 shares of Thermo Fisher Scientific worth $1.28M as of Q2 2026.
  • Westhampton Capital bought 63 Thermo Fisher Scientific shares in Q2 2026, an estimated $30.2K.
  • Thermo Fisher Scientific made up 0.53% of Westhampton Capital's portfolio in Q2 2026, its #54 holding.
  • Westhampton Capital first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 29 quarters since.
  • Westhampton Capital's Thermo Fisher Scientific position peaked at $1.44M in Q4 2025.
  • 875 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Westhampton Capital's 13F filing for Q2 2026, filed 14 Jul 2026.